Publication

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Publications related to Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer | EPFL Graph Search

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Graph Chatbot

Chat with Graph Search

Androgen Receptor Signaling in in vivo models of Estrogen Receptor-positive Breast Cancer and Normal Breast Epithelium

Unveiling breast cancer metastasis through an advanced X-ray imaging approach

Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?

Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial

A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation

Development of cysteine cathepsin inhibitors combined with cell type-specific delivery for the treatment of B-cell lymphoma and solid tumors

Exploration and modulation of mechanical cues for enhanced cancer immunotherapy

Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy

Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth

Ru(II)-Arene Complexes of Curcumin and Bisdesmethoxycurcumin Metabolites